CN Bio Appoints Dr. Samantha Macro as Chief Financial Officer   •   80-20 Educational Foundation Calls for Fair Coverage of Asian Americans in Supreme Court Case   •   Children's Hospital of Philadelphia Celebrates 27th Annual Fetal Surgery Family Reunion at the Philadelphia Zoo   •   Los Angeles Public Library to Host Inaugural Juneteenth Celebration "June Jubilee: A Celebration of Black Excellence"   •   On Lok Partners with San Francisco Health Plan to provide Enhanced Care Management to Eligible Medi-Cal Enrollees   •   Carbios Aims to be a Leader in Growing r-PET Market with an Ambition to Capture 8 to 12% Share by 2035 Through Licensing Model   •   HH Global aligned to the Net Zero Standard   •   Transgene and NEC Present New Data on TG4050, an Individualized Cancer Vaccine, Showing it Induces Specific Immune Responses aga   •   The Jeff T. Green Family Foundation Invests in Team Dayā, to Build a Primary School in Nicaragua   •   FNKO INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Funko, Inc. Investors with Substantial Losses Have O   •   LAZR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Luminar Technologies, Inc. Investors with Substantia   •   AHF Demands LA County Step Up to Stem STIs   •   FIBRA Prologis Receives Investment Grade Credit Rating of BBB+ from S&P   •   Nation's Finest Marks 50th Anniversary with Milestone Event Honoring the Nation's Finest 50 Leaders Who Have Gone Above and Beyo   •   Hard Rock Hotel New York introduces experiences for guests to "Love Out Loud" this June   •   Hyundai Canada's Don Romano honoured with WXN 2023 Canadian Equity, Diversity and Inclusion (CEDI) Award   •   Zura Bio Completes Approximately $80 Million Financing with the Focus on Advancing ZB-106, a Potential First-in-class Anti-IL-17   •   NEE INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that NextEra Energy, Inc. Investors with Substantial Losse   •   Government of Canada Supports Projects to Prevent and Address Family Violence in British Columbia   •   OSE Immunotherapeutics Presents Clinical Abstracts on Tedopi® at the ASCO 2023 Annual Meeting